Psychiatric News (5/26) highlights a case report published in Schizophrenia Bulletin, which “suggests that patients who are taking clozapine may be at risk of clozapine toxicity if they become infected with” coronavirus. Psychiatric News adds, “Clozapine is considered the best option for patients with treatment-resistant schizophrenia, but patients taking the medication are at heightened risk of a rare but serious condition known as neutropenia, which can increase risk of severe infections.”
Related Links:
— “Potential Risk of Clozapine Toxicity May Occur in Patients With COVID-19, Psychiatric News, May 26, 2020